SingHealth to double down on pop health analytics, AI digital pathology
SingHealth to double down on pop health analytics, AI digital pathology | Healthcare IT News…
Continue ReadingSingHealth to double down on pop health analytics, AI digital pathology | Healthcare IT News…
Continue ReadingKameda Medical Center sets up AI digital pathology and more briefs | Healthcare IT News…
Continue ReadingMichael Campbell, Chief Product Officer at Hyland, is blunt about where digital pathology struggles today. Adoption is moving, but the operational scaffolding has not kept pace. Hyland is addressing this challenge by bringing its…
Continue ReadingCloud imaging was supposed to simplify everything. Instead, many health systems inherited slower rollouts, higher costs, and workflows that still feel anchored to a data center. The problem was never the cloud itself. It…
Continue ReadingCloud imaging promised speed and simplicity. Many health systems got longer rollouts, higher costs, and workflows that still feel tied to the data center. The issue isn’t the cloud. It’s how imaging platforms were…
Continue ReadingWhat You Should Know:
– PathAI has secured a historic regulatory milestone with the FDA qualification of its AIM-MASH AI Assist tool, making it the first AI-powered pathology biomarker to receive such status under the…
Continue ReadingEvery booth at RSNA25 had something new—but the real story was what they all had in common. After three days on the floor, one theme kept surfacing no matter which vendor I spoke with.In…
Continue ReadingMultimodal models have enabled the integration of digital pathology, radiology, clinical information, and omics data to enhance Colorectal cancer (CRC) care. This systematic review critically appraises Multimodal digital pathology techniques applied in CRC, their…
Continue ReadingWhat You Should Know:
– Lunit, a provider of AI for cancer diagnostics and precision oncology, and Labcorp, a global leader in innovative and comprehensive laboratory services, today announced a strategic collaborative initiative. The partnership…
Continue ReadingPotentially malignant oral lesions are visible mucosal changes with risk of progressing to squamous cell carcinoma. These lesions are currently graded as no, mild, moderate, or severe dysplasia per WHO guidelines. While widely used,…
Continue Reading